Study of ONCOFID-P-B (PACLITAXEL-HYALURONIC ACID)

NCT05024773 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

112

Enrollment

INDUSTRY

Sponsor class

Conditions

Bladder Carcinoma in Situ (CIS)

Interventions

DRUG: ONCOFID P-B (PACLITAXEL-HYALURONIC ACID)

Sponsor

Fidia Farmaceutici s.p.a.